MALAT1 and neoplasm: One of the most intensively researched possible biomarkers for detecting NSCLC is metastasis-associated lung adenocarcinoma transcript 1(MALAT1), which accelerates tumor migration and proliferation by suppressing cell apoptosis shortening the cell cycle when highly expressed in NSCLC patient serum [189].